• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

February 2007: Additions and Deletions to the Drug Product List

27th Edition: Cumulative Supplement Number 2

Prescription     OTC

NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.6 Cumulative Supplement Legend.


ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
    ABARELIX
          INJECTABLE; INTRAMUSCULAR
            PLENAXIS
>D>         @ PRAECIS                    100MG/VIAL                              N21320 001  Nov 25, 2003    Feb  CAHN
>A>         @ SPECIALITY EUROPEAN        100MG/VIAL                              N21320 001  Nov 25, 2003    Feb  CAHN

        ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
          TABLET; ORAL
            ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
>D>   AB  +   MIKART                     712.8MG;60MG;32MG                       N40316 001  Apr 28, 1999    Feb  CTEC
>A>   AA  +                              712.8MG;60MG;32MG                       N40316 001  Apr 28, 1999    Feb  CTEC
            ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITATRATE
>D>   AB      WEST WARD                  712.8MG;60MG;32MG                       N40637 001  Sep 22, 2006    Feb  CTEC
>A>   AA                                 712.8MG;60MG;32MG                       N40637 001  Sep 22, 2006    Feb  CTEC
        ACETAMINOPHEN; HYDROCODONE BITARTRATE
          TABLET; ORAL
            HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A>   AA      INTERPHARM                 500MG;10MG                              N40813 001  Feb 23, 2007    Feb  NEWA

        ALPRAZOLAM
          TABLET, EXTENDED RELEASE; ORAL
            ALPRAZOLAM
>A>   AB      TEVA PHARMS                0.5MG                                   N77979 001  Feb 28, 2007    Feb  NEWA
>A>   AB                                 1MG                                     N77979 002  Feb 28, 2007    Feb  NEWA
>A>   AB                                 2MG                                     N77979 003  Feb 28, 2007    Feb  NEWA
>A>   AB                                 3MG                                     N77979 004  Feb 28, 2007    Feb  NEWA
          TABLET; ORAL
            ALPRAZOLAM
>D>         @ CLONMEL HLTHCARE           0.25MG                                  N74174 001  Oct 19, 1993    Feb  CAHN
>D>         @                            0.5MG                                   N74174 002  Oct 19, 1993    Feb  CAHN
>D>         @                            1MG                                     N74174 003  Oct 19, 1993    Feb  CAHN
>D>         @                            2MG                                     N74174 004  Oct 19, 1993    Feb  CAHN
>A>         @ DAVA INTL INC              0.25MG                                  N74174 001  Oct 19, 1993    Feb  CAHN
>A>         @                            0.5MG                                   N74174 002  Oct 19, 1993    Feb  CAHN
>A>         @                            1MG                                     N74174 003  Oct 19, 1993    Feb  CAHN
>A>         @                            2MG                                     N74174 004  Oct 19, 1993    Feb  CAHN

        ARIPIPRAZOLE
          TABLET, ORALLY DISINTEGRATING; ORAL
            ABILIFY
>D>           OTSUKA                     10MG                                    N21729 002  Jun 07, 2006    Feb  CRLD
>A>       +                              10MG                                    N21729 002  Jun 07, 2006    Feb  CRLD
>D>       +                              30MG                                    N21729 005  Jun 07, 2006    Feb  CRLD
>A>                                      30MG                                    N21729 005  Jun 07, 2006    Feb  CRLD
          TABLET; ORAL
            ABILIFY
>D>       +   OTSUKA                     15MG                                    N21436 002  Nov 15, 2002    Feb  CRLD
>A>                                      15MG                                    N21436 002  Nov 15, 2002    Feb  CRLD
>D>       +                              30MG                                    N21436 004  Nov 15, 2002    Feb  CRLD
>A>                                      30MG                                    N21436 004  Nov 15, 2002    Feb  CRLD

        BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
          OINTMENT; OPHTHALMIC
>D>         CORTISPORIN
>D>   AT      MONARCH PHARMS             400 UNITS/GM;1%;EQ 3.5MG                N50416 002                  Feb  DISC
>A>         @                            400 UNITS/GM;1%;EQ 3.5MG                N50416 002                  Feb  DISC
            NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
>D>   AT  +   BAUSCH AND LOMB            400 UNITS/GM;1%;EQ 3.5MG                N64068 001  Oct 30, 1995    Feb  CTEC
>A>       +                              400 UNITS/GM;1%;EQ 3.5MG                N64068 001  Oct 30, 1995    Feb  CTEC

        BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
          OINTMENT; OPHTHALMIC
>D>         NEOSPORIN
>D>   AT      MONARCH PHARMS             400 UNITS/GM;EQ 3.5MG                   N50417 001                  Feb  DISC
>A>         @                            400 UNITS/GM;EQ 3.5MG                   N50417 001                  Feb  DISC

        BACITRACIN ZINC; POLYMYXIN B SULFATE
          OINTMENT; OPHTHALMIC
>D>         POLYSPORIN
>D>   AT      MONARCH PHARMS             500 UNITS/GM;10,000 UNITS/GM            N61229 001                  Feb  DISC
>A>         @                            500 UNITS/GM;10,000 UNITS/GM            N61229 001                  Feb  DISC

        BUDESONIDE
          POWDER, METERED; INHALATION
>D>         BUDESONIDE
>D>           ASTRAZENECA                0.08MG/INH                              N21949 001  Jul 12, 2006    Feb  CTNA
>D>       +                              0.16MG/INH                              N21949 002  Jul 12, 2006    Feb  CTNA
>A>         PULMICORT FLEXHALER
>A>           ASTRAZENECA                0.08MG/INH                              N21949 001  Jul 12, 2006    Feb  CTNA
>A>       +                              0.16MG/INH                              N21949 002  Jul 12, 2006    Feb  CTNA

        CABERGOLINE
          TABLET; ORAL
            CABERGOLINE
>A>   AB      IVAX PHARMS INC            0.5MG                                   N77750 001  Mar 07, 2007    Feb  NEWA

        CARISOPRODOL
          TABLET; ORAL
            CARISOPRODOL
>A>   AA      SUN PHARM INDS LTD         350MG                                   N40755 001  Feb 27, 2007    Feb  NEWA

        CEFTIZOXIME SODIUM
          INJECTABLE; INJECTION
            CEFIZOX
>D>           ASTELLAS                   EQ 1GM BASE/VIAL                        N63294 002  Mar 31, 1994    Feb  CRLD
>A>       +                              EQ 1GM BASE/VIAL                        N63294 002  Mar 31, 1994    Feb  CRLD
>D>       +                              EQ 1GM BASE/VIAL                        N50560 002  Sep 15, 1983    Feb  DISC
>A>         @                            EQ 1GM BASE/VIAL                        N50560 002  Sep 15, 1983    Feb  DISC

        CEFTRIAXONE SODIUM
          INJECTABLE; IM-IV
            CEFTRIAXONE
>A>   AP      HANFORD GC                 EQ 1GM BASE/VIAL                        N65268 001  Feb 28, 2007    Feb  NEWA
>A>   AP                                 EQ 2GM BASE/VIAL                        N65268 002  Feb 28, 2007    Feb  NEWA
          INJECTABLE; INJECTION
            CEFTRIAXONE
>A>   AP      HANFORD GC                 EQ 10GM BASE/VIAL                       N65269 001  Feb 28, 2007    Feb  NEWA

        CHLORAMPHENICOL SODIUM SUCCINATE
          INJECTABLE; INJECTION
            CHLORAMPHENICOL SODIUM SUCCINATE
>D>   AP      ABRAXIS PHARM              EQ 1GM BASE/VIAL                        N62365 001  Aug 25, 1982    Feb  CRLD
>A>       +                              EQ 1GM BASE/VIAL                        N62365 001  Aug 25, 1982    Feb  CRLD
>D>         CHLOROMYCETIN
>D>   AP  +   PARKEDALE                  EQ 1GM BASE/VIAL                        N50155 001                  Feb  DISC
>A>         @                            EQ 1GM BASE/VIAL                        N50155 001                  Feb  DISC

        CHLOROTHIAZIDE
          SUSPENSION; ORAL
            DIURIL
>D>       +   MERCK                      250MG/5ML                               N11870 001                  Feb  CAHN
>A>       +   SALIX PHARMS               250MG/5ML                               N11870 001                  Feb  CAHN

        CITALOPRAM HYDROBROMIDE
>A>       CAPSULE; ORAL
>A>         CITALOPRAM HYDROBROMIDE
>A>           ALPHAPHARM                 EQ 10MG BASE                            N77668 001  Feb 28, 2007    Feb  NEWA
>A>                                      EQ 20MG BASE                            N77668 002  Feb 28, 2007    Feb  NEWA
>A>       +                              EQ 40MG BASE                            N77668 003  Feb 28, 2007    Feb  NEWA

        CLOBETASOL PROPIONATE
          SOLUTION; TOPICAL
            CLOBETASOL PROPIONATE
>D>         @ ALTANA                     0.05%                                   N75391 001  Feb 08, 1999    Feb  CMFD
>A>   AT                                 0.05%                                   N75391 001  Feb 08, 1999    Feb  CMFD

        CLONIDINE HYDROCHLORIDE
          TABLET; ORAL
            CLONIDINE HYDROCHLORIDE
>A>   AB      VINTAGE                    0.1MG                                   N77901 001  Mar 09, 2007    Feb  NEWA
>A>   AB                                 0.2MG                                   N77901 002  Mar 09, 2007    Feb  NEWA
>A>   AB                                 0.3MG                                   N77901 003  Mar 09, 2007    Feb  NEWA

        CYCLOBENZAPRINE HYDROCHLORIDE
>A>       CAPSULE, EXTENDED RELEASE; ORAL
>A>         AMRIX
>A>           ECR                        15MG                                    N21777 001  Feb 01, 2007    Feb  NEWA
>A>       +                              30MG                                    N21777 002  Feb 01, 2007    Feb  NEWA
          TABLET; ORAL
            CYCLOBENZAPRINE HYDROCHLORIDE
>A>   AB      VINTAGE PHARMS             5MG                                     N77797 001  Feb 28, 2007    Feb  NEWA
>A>   AB                                 10MG                                    N77797 002  Feb 28, 2007    Feb  NEWA

        DEXTROAMPHETAMINE SULFATE
          TABLET; ORAL
>D>         DEXEDRINE
>D>   AA      GLAXOSMITHKLINE            5MG                                     N84935 001                  Feb  DISC
>A>         @                            5MG                                     N84935 001                  Feb  DISC

        DIDANOSINE
          FOR SOLUTION; ORAL
>A>         DIDANOSINE
>A>   AA      AUROBINDO PHARMA           10MG/ML                                 N78112 001  Mar 08, 2007    Feb  NEWA
            VIDEX
>D>       +   BRISTOL MYERS              10MG/ML                                 N20156 001  Oct 09, 1991    Feb  CFTG
>A>   AA  +                              10MG/ML                                 N20156 001  Oct 09, 1991    Feb  CFTG

        DIMYRISTOYL LECITHIN; PERFLEXANE
          INJECTABLE; INTRAVENOUS
            IMAGENT
>D>         @ IMCOR PH                   0.92MG/VIAL;0.092MG/VIAL                N21191 001  May 31, 2002    Feb  CAHN
>A>         @ IMCOR PHARMS CO            0.92MG/VIAL;0.092MG/VIAL                N21191 001  May 31, 2002    Feb  CAHN

        ESTRADIOL
          TABLET; ORAL
            ESTRADIOL
>A>         @ HERITAGE PHARMS INC        0.5MG                                   N40275 001  Dec 29, 1998    Feb  CAHN
>A>         @                            1MG                                     N40275 002  Dec 29, 1998    Feb  CAHN
>A>         @                            2MG                                     N40275 003  Dec 29, 1998    Feb  CAHN
>D>         @ RADIUS PHARMS              0.5MG                                   N40275 001  Dec 29, 1998    Feb  CAHN
>D>         @                            1MG                                     N40275 002  Dec 29, 1998    Feb  CAHN
>D>         @                            2MG                                     N40275 003  Dec 29, 1998    Feb  CAHN

        FAMOTIDINE
          FOR SUSPENSION; ORAL
            PEPCID
>D>       +   MERCK                      40MG/5ML                                N19527 001  Feb 02, 1987    Feb  CAHN
>A>       +   SALIX PHARMS               40MG/5ML                                N19527 001  Feb 02, 1987    Feb  CAHN

        FENOLDOPAM MESYLATE
          INJECTABLE; INJECTION
            FENOLDOPAM MESYLATE
>A>   AP      SICOR PHARMS               EQ 10MG BASE/ML                         N77826 001  Mar 07, 2007    Feb  NEWA

        FINASTERIDE
          TABLET; ORAL
            FINASTERIDE
>A>   AB      DR REDDYS LABS             5MG                                     N76437 001  Feb 28, 2007    Feb  NEWA

        FLUPHENAZINE HYDROCHLORIDE
          TABLET; ORAL
            FLUPHENAZINE HYDROCHLORIDE
>D>   AB      MYLAN                      10MG                                    N89804 001  Aug 12, 1988    Feb  CRLD
>A>   AB  +                              10MG                                    N89804 001  Aug 12, 1988    Feb  CRLD

        GABAPENTIN
          TABLET; ORAL
            GABAPENTIN
>D>   AB      IVAX PHARMS                800MG                                   N76017 005  Apr 29, 2005    Feb  CRLD
>A>   AB  +                              800MG                                   N76017 005  Apr 29, 2005    Feb  CRLD
            NEURONTIN
>D>   AB  +   PFIZER PHARMS              800MG                                   N20882 002  Oct 09, 1998    Feb  CRLD
>A>   AB                                 800MG                                   N20882 002  Oct 09, 1998    Feb  CRLD

        HEPARIN SODIUM
          INJECTABLE; INJECTION
            HEPARIN SODIUM
>A>         @ WATSON LABS                1,000 UNITS/ML                          N17064 002                  Feb  CAHN
>A>         @                            2,500 UNITS/ML                          N17064 015                  Feb  CAHN
>A>         @                            3,000 UNITS/ML                          N17064 016                  Feb  CAHN
>A>         @                            4,000 UNITS/ML                          N17064 017                  Feb  CAHN
>A>         @                            5,000 UNITS/ML                          N17064 003                  Feb  CAHN
>A>         @                            6,000 UNITS/ML                          N17064 018                  Feb  CAHN
>A>         @                            7,500 UNITS/ML                          N17064 019                  Feb  CAHN
>A>         @                            10,000 UNITS/ML                         N17064 004                  Feb  CAHN
>A>         @                            20,000 UNITS/ML                         N17064 005                  Feb  CAHN
>A>         @                            40,000 UNITS/ML                         N17064 006                  Feb  CAHN
>D>         @ WATSON PHARMS              1,000 UNITS/ML                          N17064 002                  Feb  CAHN
>D>         @                            2,500 UNITS/ML                          N17064 015                  Feb  CAHN
>D>         @                            3,000 UNITS/ML                          N17064 016                  Feb  CAHN
>D>         @                            4,000 UNITS/ML                          N17064 017                  Feb  CAHN
>D>         @                            5,000 UNITS/ML                          N17064 003                  Feb  CAHN
>D>         @                            6,000 UNITS/ML                          N17064 018                  Feb  CAHN
>D>         @                            7,500 UNITS/ML                          N17064 019                  Feb  CAHN
>D>         @                            10,000 UNITS/ML                         N17064 004                  Feb  CAHN
>D>         @                            20,000 UNITS/ML                         N17064 005                  Feb  CAHN
>D>         @                            40,000 UNITS/ML                         N17064 006                  Feb  CAHN

        HYDRALAZINE HYDROCHLORIDE
          TABLET; ORAL
            HYDRALAZINE HYDROCHLORIDE
>A>         @ HERITAGE PHARMS INC        25MG                                    N86243 001                  Feb  CAHN
>A>         @                            50MG                                    N86242 002                  Feb  CAHN
>D>         @ RADIUS PHARMS              25MG                                    N86243 001                  Feb  CAHN
>D>         @                            50MG                                    N86242 002                  Feb  CAHN

        HYDROCHLOROTHIAZIDE
          TABLET; ORAL
            HYDROCHLOROTHIAZIDE
>A>   AB      ACTAVIS ELIZABETH          12.5MG                                  N40707 001  Feb 27, 2007    Feb  NEWA
>A>   AB      HERITAGE PHARMS INC        25MG                                    N85181 001                  Feb  CAHN
>A>   AB                                 50MG                                    N85182 001                  Feb  CAHN
>D>   AB      LEINER                     25MG                                    N85181 001                  Feb  CAHN
>D>   AB                                 50MG                                    N85182 001                  Feb  CAHN
>D>           MYLAN                      12.5MG                                  N40770 001  Jan 23, 2007    Feb  CTEC
>A>   AB                                 12.5MG                                  N40770 001  Jan 23, 2007    Feb  CTEC

        HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
          TABLET; ORAL
>A>         MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
>A>   AB      TEVA                       12.5MG;7.5MG                            N76980 001  Mar 07, 2007    Feb  NEWA
>A>   AB                                 12.5MG;15MG                             N76980 003  Mar 07, 2007    Feb  NEWA
>A>   AB                                 25MG;15MG                               N76980 002  Mar 07, 2007    Feb  NEWA
            UNIRETIC
>D>           SCHWARZ PHARMA             12.5MG;7.5MG                            N20729 001  Jun 27, 1997    Feb  CFTG
>A>   AB                                 12.5MG;7.5MG                            N20729 001  Jun 27, 1997    Feb  CFTG
>D>                                      12.5MG;15MG                             N20729 003  Feb 14, 2002    Feb  CFTG
>A>   AB                                 12.5MG;15MG                             N20729 003  Feb 14, 2002    Feb  CFTG
>D>       +                              25MG;15MG                               N20729 002  Jun 27, 1997    Feb  CFTG
>A>   AB  +                              25MG;15MG                               N20729 002  Jun 27, 1997    Feb  CFTG

        HYDROCORTISONE
          TABLET; ORAL
            CORTEF
>D>         @ PHARMACIA AND              10MG                                    N08697 001                  Feb  CMFD
>A>                                      10MG                                    N08697 001                  Feb  CMFD

        HYDROMORPHONE HYDROCHLORIDE
          INJECTABLE; INJECTION
            HYDROMORPHONE HYDROCHLORIDE
>D>   AP      WATSON LABS                10MG/ML                                 N74317 001  Aug 23, 1995    Feb  DISC
>A>         @                            10MG/ML                                 N74317 001  Aug 23, 1995    Feb  DISC

        HYDROXYZINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            HYDROXYZINE HYDROCHLORIDE
>D>   AP      HOSPIRA                    25MG/ML                                 N87416 001                  Feb  DISC
>A>         @                            25MG/ML                                 N87416 001                  Feb  DISC
>D>   AP                                 50MG/ML                                 N87546 001                  Feb  DISC
>A>         @                            50MG/ML                                 N87546 001                  Feb  DISC
>D>   AP      WATSON LABS                50MG/ML                                 N85779 001                  Feb  DISC
>A>         @                            50MG/ML                                 N85779 001                  Feb  DISC

        ILOPROST
          SOLUTION; INHALATION
            VENTAVIS
>D>       +   ACTELION                   10UGM/ML (10UGM/ML)                     N21779 002  Dec 08, 2005    Feb  CAHN
>D>       +                              20UGM/2ML (10UGM/ML)                    N21779 001  Dec 29, 2004    Feb  CAHN
>A>       +   ACTELION PHARM             10UGM/ML (10UGM/ML)                     N21779 002  Dec 08, 2005    Feb  CAHN
>A>       +                              20UGM/2ML (10UGM/ML)                    N21779 001  Dec 29, 2004    Feb  CAHN

        INDOMETHACIN
          CAPSULE; ORAL
            INDOMETHACIN
>A>         @ HERITAGE PHARMS INC        25MG                                    N18851 001  May 18, 1984    Feb  CAHN
>A>         @                            50MG                                    N18851 002  May 18, 1984    Feb  CAHN
>D>           MYLAN                      25MG                                    N18858 001  Apr 20, 1984    Feb  CTEC
>A>   AB                                 25MG                                    N18858 001  Apr 20, 1984    Feb  CTEC
>D>         @ RADIUS PHARMS              25MG                                    N18851 001  May 18, 1984    Feb  CAHN
>D>         @                            50MG                                    N18851 002  May 18, 1984    Feb  CAHN
>D>         @ SANDOZ                     25MG                                    N70673 001  Apr 29, 1987    Feb  CMFD
>A>   AB                                 25MG                                    N70673 001  Apr 29, 1987    Feb  CMFD
>D>         @                            50MG                                    N70674 001  Apr 29, 1987    Feb  CMFD
>A>   AB                                 50MG                                    N70674 001  Apr 29, 1987    Feb  CMFD

        IRON SUCROSE
          INJECTABLE; INTRAVENOUS
            VENOFER
>D>           LUITPOLD                   EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML)     N21135 002  Mar 20, 2005    Feb  DISC
>A>         @                            EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML)     N21135 002  Mar 20, 2005    Feb  DISC
>D>                                      EQ 75MG BASE/3.75ML(EQ 20MG             N21135 003  Mar 29, 2005    Feb  DISC
>A>         @                            EQ 75MG BASE/3.75ML(EQ 20MG             N21135 003  Mar 29, 2005    Feb  DISC
>A>                                      EQ 200MG BASE/10ML(EQ 20MG              N21135 004  Feb 09, 2007    Feb  NEWA

        KETOPROFEN
          CAPSULE; ORAL
            KETOPROFEN
>A>   AB      HERITAGE PHARMS INC        25MG                                    N74014 001  Jan 29, 1993    Feb  CAHN
>A>   AB                                 50MG                                    N74014 002  Jan 29, 1993    Feb  CAHN
>A>   AB                                 75MG                                    N74014 003  Jan 29, 1993    Feb  CAHN
>D>   AB      RADIUS PHARMS              25MG                                    N74014 001  Jan 29, 1993    Feb  CAHN
>D>   AB                                 50MG                                    N74014 002  Jan 29, 1993    Feb  CAHN
>D>   AB                                 75MG                                    N74014 003  Jan 29, 1993    Feb  CAHN

        LIDOCAINE HYDROCHLORIDE
          SOLUTION; ORAL
            LIDOCAINE HYDROCHLORIDE VISCOUS
>A>   AT      VINTAGE                    2%                                      N40708 001  Feb 27, 2007    Feb  NEWA
          SOLUTION; TOPICAL
            LIDOCAINE HYDROCLORIDE
>A>   AT      VINTAGE                    4%                                      N40710 001  Feb 27, 2007    Feb  NEWA

>A>     LISDEXAMFETAMINE DIMESYLATE
>A>       CAPSULE; ORAL
>A>         VYVANSE
>A>           NEW RIVER                  30MG                                    N21977 001  Feb 23, 2007    Feb  NEWA
>A>                                      50MG                                    N21977 002  Feb 23, 2007    Feb  NEWA
>A>       +                              70MG                                    N21977 003  Feb 23, 2007    Feb  NEWA

        LOVASTATIN
          TABLET, EXTENDED RELEASE; ORAL
            ALTOPREV
>D>           ANDRX LABS LLC             10MG                                    N21316 001  Jun 26, 2002    Feb  DISC
>A>         @                            10MG                                    N21316 001  Jun 26, 2002    Feb  DISC
          TABLET; ORAL
            LOVASTATIN
>A>   AB      APOTEX INC                 10MG                                    N77748 001  Feb 28, 2007    Feb  NEWA
>A>   AB                                 20MG                                    N77748 002  Feb 28, 2007    Feb  NEWA
>A>   AB                                 40MG                                    N77748 003  Feb 28, 2007    Feb  NEWA

        METHYLPHENIDATE HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
            CONCERTA
>D>           ALZA                       18MG                                    N21121 001  Aug 01, 2000    Feb  CAHN
>D>                                      27MG                                    N21121 004  Apr 01, 2002    Feb  CAHN
>D>                                      36MG                                    N21121 002  Aug 01, 2000    Feb  CAHN
>D>       +                              54MG                                    N21121 003  Dec 08, 2000    Feb  CAHN
>A>           JOHNSON AND                18MG                                    N21121 001  Aug 01, 2000    Feb  CAHN
>A>                                      27MG                                    N21121 004  Apr 01, 2002    Feb  CAHN
>A>                                      36MG                                    N21121 002  Aug 01, 2000    Feb  CAHN
>A>       +                              54MG                                    N21121 003  Dec 08, 2000    Feb  CAHN

        METHYLPREDNISOLONE SODIUM SUCCINATE
          INJECTABLE; INJECTION
            METHYLPREDNISOLONE SODIUM SUCCINATE
>A>   AP      BEDFORD LABS               EQ 40MG BASE/VIAL                       N40662 001  Feb 21, 2007    Feb  NEWA
>A>   AP                                 EQ 125MG BASE/VIAL                      N40641 002  Feb 21, 2007    Feb  NEWA
>A>   AP                                 EQ 500MG BASE/VIAL                      N40709 001  Feb 21, 2007    Feb  NEWA
>A>   AP                                 EQ 500MG BASE/VIAL                      N40641 003  Feb 21, 2007    Feb  NEWA
>A>   AP                                 EQ 1GM BASE/VIAL                        N40709 002  Feb 21, 2007    Feb  NEWA
>A>   AP                                 EQ 1GM BASE/VIAL                        N40641 004  Feb 21, 2007    Feb  NEWA

        MIDAZOLAM HYDROCHLORIDE
          INJECTABLE; INJECTION
>D>         MIDAZOLAM HYDROCHLORIDE
>D>   AP  +   HOSPIRA                    EQ 1MG BASE/ML                          N75857 001  Jul 22, 2002    Feb  CTNA
>D>   AP  +                              EQ 5MG BASE/ML                          N75857 002  Jul 22, 2002    Feb  CTNA
>A>   AP      TAYLOR                     EQ 1MG BASE/ML                          N75494 001  Jun 30, 2000    Feb  CAHN
>A>   AP                                 EQ 5MG BASE/ML                          N75494 002  Jun 30, 2000    Feb  CAHN
>D>   AP      TAYLOR PHARMA              EQ 1MG BASE/ML                          N75494 001  Jun 30, 2000    Feb  CAHN
>D>   AP                                 EQ 5MG BASE/ML                          N75494 002  Jun 30, 2000    Feb  CAHN
>A>         MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
>A>   AP  +   HOSPIRA                    EQ 1MG BASE/ML                          N75857 001  Jul 22, 2002    Feb  CTNA
>A>   AP  +                              EQ 5MG BASE/ML                          N75857 002  Jul 22, 2002    Feb  CTNA

        MORPHINE SULFATE
          CAPSULE, EXTENDED RELEASE; ORAL
            KADIAN
>A>           ALPHARMA US                200MG                                   N20616 007  Feb 27, 2007    Feb  NEWA

        NALBUPHINE HYDROCHLORIDE
          INJECTABLE; INJECTION
            NALBUPHINE HYDROCHLORIDE
>D>   AP      HOSPIRA                    10MG/ML                                 N70915 001  Feb 03, 1989    Feb  CRLD
>A>   AP  +                              10MG/ML                                 N70915 001  Feb 03, 1989    Feb  CRLD
>D>   AP                                 10MG/ML                                 N70914 001  Feb 03, 1989    Feb  CRLD
>A>   AP  +                              10MG/ML                                 N70914 001  Feb 03, 1989    Feb  CRLD
>D>   AP                                 20MG/ML                                 N70918 001  Feb 03, 1989    Feb  CRLD
>A>   AP  +                              20MG/ML                                 N70918 001  Feb 03, 1989    Feb  CRLD
>D>   AP                                 20MG/ML                                 N70916 001  Feb 03, 1989    Feb  CRLD
>A>   AP  +                              20MG/ML                                 N70916 001  Feb 03, 1989    Feb  CRLD
>D>         NUBAIN
>D>   AP  +   ENDO PHARMS                10MG/ML                                 N18024 001                  Feb  DISC
>A>         @                            10MG/ML                                 N18024 001                  Feb  DISC
>D>   AP  +                              20MG/ML                                 N18024 002  May 27, 1982    Feb  DISC
>A>         @                            20MG/ML                                 N18024 002  May 27, 1982    Feb  DISC

        NESIRITIDE RECOMBINANT
          FOR SOLUTION; INTRAVENOUS
            NATRECOR
>D>       +   ALZA CORP                  1.5MG/VIAL                              N20920 001  Aug 10, 2001    Feb  CAHN
>A>       +   SCIOS                      1.5MG/VIAL                              N20920 001  Aug 10, 2001    Feb  CAHN

        ONDANSETRON HYDROCHLORIDE
          INJECTABLE; INJECTION
            ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
>A>   AP      MAYNE PHARMA USA           EQ 0.64MG BASE/ML                       N76978 001  Feb 26, 2007    Feb  NEWA

        OXYCODONE HYDROCHLORIDE
          TABLET; ORAL
            ROXICODONE
>D>   AB  +   XANODYNE PHARM             15MG                                    N21011 001  Aug 31, 2000    Feb  CAHN
>D>   AB                                 30MG                                    N21011 002  Aug 31, 2000    Feb  CAHN
>A>   AB  +   XANODYNE PHARMS            15MG                                    N21011 001  Aug 31, 2000    Feb  CAHN
>A>   AB                                 30MG                                    N21011 002  Aug 31, 2000    Feb  CAHN

        PAROXETINE HYDROCHLORIDE
          TABLET; ORAL
            PAROXETINE HYDROCHLORIDE
>A>   AB      ZYDUS PHARMS USA           EQ 10MG BASE                            N77584 001  Mar 07, 2007    Feb  NEWA
>A>   AB                                 EQ 20MG BASE                            N77584 002  Mar 07, 2007    Feb  NEWA
>A>   AB                                 EQ 30MG BASE                            N77584 003  Mar 07, 2007    Feb  NEWA
>A>   AB                                 EQ 40MG BASE                            N77584 004  Mar 07, 2007    Feb  NEWA

        PENTOXIFYLLINE
          TABLET, EXTENDED RELEASE; ORAL
            PENTOXIFYLLINE
>A>   AB      HERITAGE PHARMS INC        400MG                                   N74877 001  Jul 08, 1997    Feb  CAHN
>D>   AB      RADIUS PHARMS              400MG                                   N74877 001  Jul 08, 1997    Feb  CAHN

        PHENTERMINE HYDROCHLORIDE
          CAPSULE; ORAL
            PHENTERMINE HYDROCHLORIDE
>D>   AA      AMBI PHARMS                30MG                                    N40083 001  Mar 07, 1997    Feb  CAHN
>D>   AA      SANDOZ                     30MG                                    N87190 001                  Feb  CRLD
>A>   AA  +                              30MG                                    N87190 001                  Feb  CRLD
>A>   AA      TG UNITED INC              30MG                                    N40083 001  Mar 07, 1997    Feb  CAHN

        PILOCARPINE HYDROCHLORIDE
          TABLET; ORAL
            PILOCARPINE HYDROCHLORIDE
>A>   AB      ROXANE                     7.5MG                                   N76963 002  Feb 27, 2007    Feb  NEWA

        PIPERACILLIN SODIUM
          INJECTABLE; INJECTION
            PIPERACILLIN
>D>       +   ABRAXIS PHARM              EQ 2GM BASE/VIAL                        N65114 001  Nov 14, 2003    Feb  CAHN
>D>       +                              EQ 3GM BASE/VIAL                        N65114 002  Nov 14, 2003    Feb  CAHN
>D>       +                              EQ 4GM BASE/VIAL                        N65114 003  Nov 14, 2003    Feb  CAHN
>D>       +                              EQ 40GM BASE/VIAL                       N65157 001  Jul 12, 2004    Feb  CAHN
>A>       +   ISTITUTO BIOCHIMICO        EQ 2GM BASE/VIAL                        N65114 001  Nov 14, 2003    Feb  CAHN
>A>       +                              EQ 3GM BASE/VIAL                        N65114 002  Nov 14, 2003    Feb  CAHN
>A>       +                              EQ 4GM BASE/VIAL                        N65114 003  Nov 14, 2003    Feb  CAHN
>A>       +                              EQ 40GM BASE/VIAL                       N65157 001  Jul 12, 2004    Feb  CAHN

        PREDNICARBATE
          OINTMENT; TOPICAL
            DERMATOP
>D>       +   SANOFI AVENTIS US          0.1%                                    N19568 001  Sep 23, 1991    Feb  CFTG
>A>   AB  +                              0.1%                                    N19568 001  Sep 23, 1991    Feb  CFTG
>A>         PREDNICARBATE
>A>   AB      ALTANA                     0.1%                                    N77236 001  Mar 09, 2007    Feb  NEWA

        PROCHLORPERAZINE
          SUPPOSITORY; RECTAL
>D>         COMPAZINE
>D>   AB  +   GLAXOSMITHKLINE            25MG                                    N11127 002                  Feb  DISC
>A>         @                            25MG                                    N11127 002                  Feb  DISC
            PROCHLORPERAZINE
>D>   AB      G AND W LABS               25MG                                    N40058 001  Nov 24, 1993    Feb  CRLD
>A>   AB  +                              25MG                                    N40058 001  Nov 24, 1993    Feb  CRLD

        PROCHLORPERAZINE EDISYLATE
          INJECTABLE; INJECTION
>D>         COMPAZINE
>D>   AP  +   GLAXOSMITHKLINE            EQ 5MG BASE/ML                          N10742 002                  Feb  DISC
>A>         @                            EQ 5MG BASE/ML                          N10742 002                  Feb  DISC
>D>         PROCHLORPERAZINE
>D>   AP      BAXTER HLTHCARE            EQ 5MG BASE/ML                          N87759 001  Oct 01, 1982    Feb  DISC
>A>         @                            EQ 5MG BASE/ML                          N87759 001  Oct 01, 1982    Feb  DISC
            PROCHLORPERAZINE EDISYLATE
>D>   AP      BAXTER HLTHCARE            EQ 5MG BASE/ML                          N89903 001  Aug 29, 1989    Feb  CRLD
>A>   AP  +                              EQ 5MG BASE/ML                          N89903 001  Aug 29, 1989    Feb  CRLD
>D>   AP      HOSPIRA                    EQ 5MG BASE/ML                          N89703 001  Apr 07, 1988    Feb  DISC
>A>         @                            EQ 5MG BASE/ML                          N89703 001  Apr 07, 1988    Feb  DISC
>D>   AP      WATSON LABS                EQ 5MG BASE/ML                          N89530 001  Jul 08, 1987    Feb  DISC
>A>         @                            EQ 5MG BASE/ML                          N89530 001  Jul 08, 1987    Feb  DISC

        PROCHLORPERAZINE MALEATE
          TABLET; ORAL
>D>         COMPAZINE
>D>   AB      GLAXOSMITHKLINE            EQ 5MG BASE                             N10571 001                  Feb  DISC
>A>         @                            EQ 5MG BASE                             N10571 001                  Feb  DISC
>D>   AB                                 EQ 10MG BASE                            N10571 002                  Feb  DISC
>A>         @                            EQ 10MG BASE                            N10571 002                  Feb  DISC
>D>   AB  +                              EQ 25MG BASE                            N10571 003                  Feb  DISC
>A>         @                            EQ 25MG BASE                            N10571 003                  Feb  DISC
            PROCHLORPERAZINE MALEATE
>D>   AB      SANDOZ                     EQ 10MG BASE                            N40101 002  Jul 19, 1996    Feb  CRLD
>A>   AB  +                              EQ 10MG BASE                            N40101 002  Jul 19, 1996    Feb  CRLD
>D>   AB                                 EQ 25MG BASE                            N40101 003  Jul 19, 1996    Feb  DISC
>A>         @                            EQ 25MG BASE                            N40101 003  Jul 19, 1996    Feb  DISC

        PROPOXYPHENE HYDROCHLORIDE
          CAPSULE; ORAL
            DOLENE
>A>         @ HERITAGE PHARMS INC        65MG                                    N80530 001                  Feb  CAHN
>D>         @ RADIUS PHARMS              65MG                                    N80530 001                  Feb  CAHN

        PROPRANOLOL HYDROCHLORIDE
          CAPSULE, EXTENDED RELEASE; ORAL
            PROPRANOLOL HYDROCHLORIDE
>A>   AB      MYLAN                      60MG                                    N78022 001  Feb 15, 2007    Feb  NEWA
>A>   AB                                 80MG                                    N78022 002  Feb 15, 2007    Feb  NEWA
>A>   AB                                 120MG                                   N78022 003  Feb 15, 2007    Feb  NEWA
>A>   AB                                 160MG                                   N78022 004  Feb 15, 2007    Feb  NEWA

        RABEPRAZOLE SODIUM
          TABLET, DELAYED RELEASE; ORAL
            ACIPHEX
>D>       +   EISAI MEDCL RES            20MG                                    N20973 002  Aug 19, 1999    Feb  CFTG
>A>   AB  +                              20MG                                    N20973 002  Aug 19, 1999    Feb  CFTG
>A>         RABEPRAZOLE SODIUM
>A>   AB      TEVA                       20MG                                    N76822 001  Feb 21, 2007    Feb  NEWA

        RAMIPRIL
>A>       TABLET; ORAL
>A>         ALTACE
>A>           COBALT                     1.25MG                                  N22021 001  Feb 27, 2007    Feb  NEWA
>A>                                      2.5MG                                   N22021 002  Feb 27, 2007    Feb  NEWA
>A>                                      5MG                                     N22021 003  Feb 27, 2007    Feb  NEWA
>A>       +                              10MG                                    N22021 004  Feb 27, 2007    Feb  NEWA

        RANITIDINE HYDROCHLORIDE
          SYRUP; ORAL
>A>         RANITIDINE HYDROCHLORIDE
>A>   AA      ALPHARMA US                EQ 15MG BASE/ML                         N76124 001  Feb 21, 2007    Feb  NEWA
            ZANTAC
>D>       +   GLAXOSMITHKLINE            EQ 15MG BASE/ML                         N19675 001  Dec 30, 1988    Feb  CFTG
>A>   AA  +                              EQ 15MG BASE/ML                         N19675 001  Dec 30, 1988    Feb  CFTG

        SERMORELIN ACETATE
          INJECTABLE; INJECTION
            GEREF
>A>       +   EMD SERONO                 EQ 0.05MG BASE/AMP                      N19863 001  Dec 28, 1990    Feb  CAHN
>A>         @                            EQ 0.5MG BASE/VIAL                      N20443 001  Sep 26, 1997    Feb  CAHN
>A>         @                            EQ 1MG BASE/VIAL                        N20443 002  Sep 26, 1997    Feb  CAHN
>D>       +   SERONO                     EQ 0.05MG BASE/AMP                      N19863 001  Dec 28, 1990    Feb  CAHN
>D>         @                            EQ 0.5MG BASE/VIAL                      N20443 001  Sep 26, 1997    Feb  CAHN
>D>         @                            EQ 1MG BASE/VIAL                        N20443 002  Sep 26, 1997    Feb  CAHN

        SERTRALINE HYDROCHLORIDE
          CONCENTRATE; ORAL
            SERTRALINE HYDROCHLORIDE
>D>   AB      RANBAXY                    EQ 20MG BASE/ML                         N78053 001  Feb 05, 2007    Feb  CTEC
>A>   AA                                 EQ 20MG BASE/ML                         N78053 001  Feb 05, 2007    Feb  CTEC
>D>   AB      ROXANE                     EQ 20MG BASE/ML                         N76934 001  Jun 30, 2006    Feb  CTEC
>A>   AA                                 EQ 20MG BASE/ML                         N76934 001  Jun 30, 2006    Feb  CTEC
            ZOLOFT
>D>   AB  +   PFIZER                     EQ 20MG BASE/ML                         N20990 001  Dec 07, 1999    Feb  CTEC
>A>   AA  +                              EQ 20MG BASE/ML                         N20990 001  Dec 07, 1999    Feb  CTEC

        SODIUM LACTATE
          INJECTABLE; INJECTION
            SODIUM LACTATE IN PLASTIC CONTAINER
>D>           HOSPIRA                    5MEQ/ML                                 N18947 001  Sep 05, 1984    Feb  CRLD
>A>       +                              5MEQ/ML                                 N18947 001  Sep 05, 1984    Feb  CRLD

        SOMATROPIN RECOMBINANT
          INJECTABLE; INJECTION
            SAIZEN
>A>   BX      EMD SERONO                 4MG/VIAL                                N19764 005  Jan 16, 2007    Feb  CAHN
>A>   BX                                 5MG/VIAL                                N19764 002  Oct 08, 1996    Feb  CAHN
>A>         @                            6MG/VIAL                                N19764 001  Oct 08, 1996    Feb  CAHN
>A>       +                              8.8MG/VIAL                              N19764 003  Aug 29, 2000    Feb  CAHN
>D>   BX      SERONO                     4MG/VIAL                                N19764 005  Jan 16, 2007    Feb  CAHN
>D>   BX                                 5MG/VIAL                                N19764 002  Oct 08, 1996    Feb  CAHN
>D>         @                            6MG/VIAL                                N19764 001  Oct 08, 1996    Feb  CAHN
>D>       +                              8.8MG/VIAL                              N19764 003  Aug 29, 2000    Feb  CAHN
            SEROSTIM
>A>   BX      EMD SERONO                 4MG/VIAL                                N20604 003  Jul 25, 1997    Feb  CAHN
>A>   BX                                 5MG/VIAL                                N20604 002  Aug 23, 1996    Feb  CAHN
>A>   BX                                 6MG/VIAL                                N20604 001  Aug 23, 1996    Feb  CAHN
>A>         @                            8.8MG/VIAL                              N20604 004  Sep 06, 2001    Feb  CAHN
>D>   BX      SERONO                     4MG/VIAL                                N20604 003  Jul 25, 1997    Feb  CAHN
>D>   BX                                 5MG/VIAL                                N20604 002  Aug 23, 1996    Feb  CAHN
>D>   BX                                 6MG/VIAL                                N20604 001  Aug 23, 1996    Feb  CAHN
>D>         @                            8.8MG/VIAL                              N20604 004  Sep 06, 2001    Feb  CAHN
          INJECTABLE; SUBCUTANEOUS
            SEROSTIM LQ
>A>         @ EMD SERONO                 6MG/0.5ML                               N20604 005  Feb 11, 2005    Feb  CAHN
>D>         @ SERONO                     6MG/0.5ML                               N20604 005  Feb 11, 2005    Feb  CAHN

        SULFAMETHOXAZOLE; TRIMETHOPRIM
          INJECTABLE; INJECTION
>D>         BACTRIM
>D>   AP  +   MUTUAL PHARM               80MG/ML;16MG/ML                         N18374 001                  Feb  DISC
>A>         @                            80MG/ML;16MG/ML                         N18374 001                  Feb  DISC
          SUSPENSION; ORAL
>D>         BACTRIM PEDIATRIC
>D>   AB      MUTUAL PHARM               200MG/5ML;40MG/5ML                      N17560 002                  Feb  DISC
>A>         @                            200MG/5ML;40MG/5ML                      N17560 002                  Feb  DISC
>D>         SEPTRA
>D>   AB  +   MONARCH PHARMS             200MG/5ML;40MG/5ML                      N17598 001                  Feb  DISC
>A>         @                            200MG/5ML;40MG/5ML                      N17598 001                  Feb  DISC
>D>         SEPTRA GRAPE
>D>   AB      MONARCH PHARMS             200MG/5ML;40MG/5ML                      N17598 002  Feb 12, 1986    Feb  DISC
>A>         @                            200MG/5ML;40MG/5ML                      N17598 002  Feb 12, 1986    Feb  DISC
            SULFAMETHOXAZOLE AND TRIMETHOPRIM
>D>   AB      TEVA                       200MG/5ML;40MG/5ML                      N18812 001  Jan 28, 1983    Feb  DISC
>A>         @                            200MG/5ML;40MG/5ML                      N18812 001  Jan 28, 1983    Feb  DISC
>D>   AB                                 200MG/5ML;40MG/5ML                      N18812 002  Jun 10, 1983    Feb  DISC
>A>         @                            200MG/5ML;40MG/5ML                      N18812 002  Jun 10, 1983    Feb  DISC
>D>   AB      TEVA PHARMS                200MG/5ML;40MG/5ML                      N77612 001  Nov 13, 2006    Feb  CRLD
>A>   AB  +                              200MG/5ML;40MG/5ML                      N77612 001  Nov 13, 2006    Feb  CRLD

        SULFASALAZINE
          TABLET; ORAL
            SULFASALAZINE
>A>         @ HERITAGE PHARMS INC        500MG                                   N80197 001                  Feb  CAHN
>D>         @ RADIUS PHARMS              500MG                                   N80197 001                  Feb  CAHN

        SULINDAC
          TABLET; ORAL
            SULINDAC
>A>         @ HERITAGE PHARMS INC        150MG                                   N73262 002  Sep 06, 1991    Feb  CAHN
>A>         @                            200MG                                   N73262 001  Sep 06, 1991    Feb  CAHN
>D>         @ RADIUS PHARMS              150MG                                   N73262 002  Sep 06, 1991    Feb  CAHN
>D>         @                            200MG                                   N73262 001  Sep 06, 1991    Feb  CAHN

        TERCONAZOLE
          SUPPOSITORY; VAGINAL
            TERCONAZOLE
>A>   AB      TARO                       80MG                                    N77553 001  Mar 09, 2007    Feb  NEWA

        THEOPHYLLINE
          TABLET, EXTENDED RELEASE; ORAL
>D>         QUIBRON-T/SR
>D>   BC      MONARCH PHARMS             300MG                                   N87563 001  Jun 21, 1983    Feb  DISC
>A>         @                            300MG                                   N87563 001  Jun 21, 1983    Feb  DISC
          TABLET; ORAL
>D>         QUIBRON-T
>D>       +   MONARCH PHARMS             300MG                                   N88656 001  Aug 22, 1985    Feb  DISC
>A>         @                            300MG                                   N88656 001  Aug 22, 1985    Feb  DISC

        TRAMADOL HYDROCHLORIDE
          TABLET, EXTENDED RELEASE; ORAL
>D>         TRAMADOL HYDROCHLORIDE
>D>           BIOVAIL LABS INTL          100MG                                   N21692 001  Sep 08, 2005    Feb  CTNA
>D>                                      200MG                                   N21692 002  Sep 08, 2005    Feb  CTNA
>D>       +                              300MG                                   N21692 003  Sep 08, 2005    Feb  CTNA
>A>         ULTRAM ER
>A>           BIOVAIL LABS INTL          100MG                                   N21692 001  Sep 08, 2005    Feb  CTNA
>A>                                      200MG                                   N21692 002  Sep 08, 2005    Feb  CTNA
>A>       +                              300MG                                   N21692 003  Sep 08, 2005    Feb  CTNA

        VERAPAMIL HYDROCHLORIDE
          INJECTABLE; INJECTION
>D>         ISOPTIN
>D>   AP  +   FSC                        2.5MG/ML                                N18485 001                  Feb  DISC
>A>         @                            2.5MG/ML                                N18485 001                  Feb  DISC
            VERAPAMIL HYDROCHLORIDE
>D>   AP      LUITPOLD                   2.5MG/ML                                N70617 001  Nov 12, 1985    Feb  CRLD
>A>   AP  +                              2.5MG/ML                                N70617 001  Nov 12, 1985    Feb  CRLD
>D>   AP                                 2.5MG/ML                                N70225 001  Nov 12, 1985    Feb  DISC
>A>         @                            2.5MG/ML                                N70225 001  Nov 12, 1985    Feb  DISC
          TABLET; ORAL
            CALAN
>D>   AB      GD SEARLE LLC              120MG                                   N18817 002  Sep 10, 1984    Feb  CRLD
>A>   AB  +                              120MG                                   N18817 002  Sep 10, 1984    Feb  CRLD
>D>         ISOPTIN
>D>   AB      FSC                        40MG                                    N18593 003  Nov 23, 1987    Feb  DISC
>A>         @                            40MG                                    N18593 003  Nov 23, 1987    Feb  DISC
>D>   AB                                 80MG                                    N18593 001  Mar 08, 1982    Feb  DISC
>A>         @                            80MG                                    N18593 001  Mar 08, 1982    Feb  DISC
>D>   AB  +                              120MG                                   N18593 002  Mar 08, 1982    Feb  DISC
>A>         @                            120MG                                   N18593 002  Mar 08, 1982    Feb  DISC
            VERAPAMIL HYDROCHLORIDE
>A>         @ HERITAGE PHARMS INC        80MG                                    N71880 001  Apr 05, 1988    Feb  CAHN
>A>         @                            120MG                                   N71881 001  Apr 05, 1988    Feb  CAHN
>D>         @ RADIUS PHARMS              80MG                                    N71880 001  Apr 05, 1988    Feb  CAHN
>D>         @                            120MG                                   N71881 001  Apr 05, 1988    Feb  CAHN

        ZONISAMIDE
          CAPSULE; ORAL
            ZONISAMIDE
>A>   AB      COREPHARMA                 25MG                                    N77876 001  Feb 21, 2007    Feb  NEWA
>A>   AB                                 50MG                                    N77876 002  Feb 21, 2007    Feb  NEWA
>A>   AB                                 100MG                                   N77876 003  Feb 21, 2007    Feb  NEWA

 

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

    CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
          SPONGE; TOPICAL
            CHLORAPREP WITH TINT
>A>       +   ENTURIA INC                2%;70% (3ML)                            N20832 007  Oct 10, 2006    Feb  NEWA

        DOXYLAMINE SUCCINATE
          TABLET; ORAL
            UNISOM
>A>       +   CHATTEM                    25MG                                    N18066 001                  Feb  CAHN
>D>       +   MCNEIL CONS                25MG                                    N18066 001                  Feb  CAHN

        NONOXYNOL-9
          SPONGE; VAGINAL
            TODAY
>D>         @ ALLENDALE PHARMS           1GM                                     N18683 001  Apr 01, 1983    Feb  CMFD
>A>       +                              1GM                                     N18683 001  Apr 01, 1983    Feb  CMFD

        ORLISTAT
          CAPSULE; ORAL
>A>         ALLI
>A>       +   GLAXOSMITHKLINE            60MG                                    N21887 001  Feb 07, 2007    Feb  NEWA

        RANITIDINE HYDROCHLORIDE
          TABLET, EFFERVESCENT; ORAL
            ZANTAC 75
>A>         @ BOEHRINGER                 EQ 75MG BASE                            N20745 001  Feb 26, 1998    Feb  CAHN
>D>         @ MCNEIL CONS                EQ 75MG BASE                            N20745 001  Feb 26, 1998    Feb  CAHN

 

 
-